Sussex Clinic Limited 03098462 false 2023-10-01 2024-09-30 2024-09-30 The principal activity of the company is the operation of a nursing home. Digita Accounts Production Advanced 6.30.9574.0 true 03098462 2023-10-01 2024-09-30 03098462 2024-09-30 03098462 bus:Director1 1 2024-09-30 03098462 bus:Director3 1 2024-09-30 03098462 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-09-30 03098462 core:CurrentFinancialInstruments 2024-09-30 03098462 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 03098462 bus:SmallEntities 2023-10-01 2024-09-30 03098462 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 03098462 bus:FilletedAccounts 2023-10-01 2024-09-30 03098462 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 03098462 bus:RegisteredOffice 2023-10-01 2024-09-30 03098462 bus:Director1 2023-10-01 2024-09-30 03098462 bus:Director1 1 2023-10-01 2024-09-30 03098462 bus:Director3 2023-10-01 2024-09-30 03098462 bus:Director3 1 2023-10-01 2024-09-30 03098462 bus:OrdinaryShareClass1 bus:CumulativeShares 2023-10-01 2024-09-30 03098462 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 03098462 countries:AllCountries 2023-10-01 2024-09-30 03098462 bus:Director1 1 2023-09-30 03098462 bus:Director3 1 2023-09-30 03098462 2022-10-01 2023-09-30 03098462 2023-09-30 03098462 bus:Director1 1 2023-09-30 03098462 bus:Director3 1 2023-09-30 03098462 bus:OrdinaryShareClass1 bus:CumulativeShares 2023-09-30 03098462 core:CurrentFinancialInstruments 2023-09-30 03098462 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 03098462 bus:Director1 1 2022-10-01 2023-09-30 03098462 bus:Director3 1 2022-10-01 2023-09-30 03098462 bus:Director1 1 2022-09-30 03098462 bus:Director3 1 2022-09-30 iso4217:GBP xbrli:pure xbrli:shares

Sussex Clinic Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 September 2024

Registration number: 03098462

 

Sussex Clinic Limited

Contents

Statement of financial position

1

Notes to the Unaudited Financial Statements

2 to 4

 

Sussex Clinic Limited

(Registration number: 03098462)
Statement of financial position as at 30 September 2024

Note

2024
£

2023
£

Current assets

 

Debtors

4

1,842,673

1,113,899

Cash at bank and in hand

 

6,550

724,486

 

1,849,223

1,838,385

Creditors: Amounts falling due within one year

5

(1,763,552)

(1,766,160)

Net assets

 

85,671

72,225

Capital and reserves

 

Called up share capital

6

1,000

1,000

Retained earnings

84,671

71,225

Shareholders' funds

 

85,671

72,225

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the director on 23 June 2025
 

.........................................

Miss S Shoai-Naini
Director

 

Sussex Clinic Limited

Notes to the Unaudited Financial Statements
for the Year Ended 30 September 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
10 Clive Avenue
Goring by Sea
West Sussex
BN12 4SG

These financial statements were authorised for issue by the director on 23 June 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Sussex Clinic Limited

Notes to the Unaudited Financial Statements
for the Year Ended 30 September 2024

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

4

Debtors

Note

2024
£

2023
£

Amounts owed by associated companies

7

610,000

610,200

Other debtors

 

1,232,673

503,699

 

1,842,673

1,113,899

5

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Amounts owed to group undertakings and undertakings in which the company has a participating interest

7

1,758,479

1,762,980

Taxation and social security

 

3,573

1,680

Accruals and deferred income

 

1,500

1,500

 

1,763,552

1,766,160

6

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary of £1 each

1,000

1,000

1,000

1,000

       
 

Sussex Clinic Limited

Notes to the Unaudited Financial Statements
for the Year Ended 30 September 2024

7

Related party transactions

Transactions with the director

2024

At 1 October 2023
£

Advances to director
£

At 30 September 2024
£

Miss S Shoai-Naini

Loans at 2.25% per annum

87,919

1,979

89,898

Mrs M Shoai-Naini

Loans at 2.25% per annum

309,605

631,191

940,796

2023

At 1 October 2022
£

Advances to director
£

Repayments by director
£

At 30 September 2023
£

Miss S Shoai-Naini

Loans at 2.25% per annum

86,090

1,829

-

87,919

Mrs M Shoai-Naini

Loans at 2.25% per annum

909,801

13,150

(613,346)

309,605